Grace Therapeutics, Inc 10-K for FY2023
Grace Therapeutics, Inc. (GRCE)
10-K
2023-06-23
For: 2023-03-31
View Original
Added on
April 11, 2026
About this 10-K
Grace Therapeutics, Inc filed this 10-K on June 23, 2023, covering the fiscal year ended March 31, 2023 (FY2023).
Headline figures
Fiscal year ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $42.43M
- compared with a net loss of $9.82M a year earlier
- Diluted EPS
- -$0.95
- compared with -$0.27 a year earlier